ACHE and early-onset autosomal dominant Alzheimer disease: Hippeastrum stapfianum ethanol extract (EE) can potentially lead to a new option for Alzheimer’s disease treatment due to the ability to activate PPAR receptors selectively, inhibit AChE, and present antioxidant capacity under the conditions evaluated.